About this Journal Submit a Manuscript Table of Contents
Prostate Cancer
Volume 2013 (2013), Article ID 519436, 15 pages
http://dx.doi.org/10.1155/2013/519436
Review Article

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers

Laboratorio de Glicómica Funcional, IQUIBICEN-CONICET, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, C1428, Buenos Aires, Argentina

Received 20 May 2013; Revised 6 August 2013; Accepted 8 August 2013

Academic Editor: James L. Gulley

Copyright © 2013 Diego J. Laderach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [7 citations]

The following is the list of published articles that have cited the current article.

  • Zeta Tak For Yu, Koh Meng Aw Yong, and Jianping Fu, “Microfluidic Blood Cell Sorting: Now and Beyond,” Small, 2014. View at Publisher · View at Google Scholar
  • Helen Blanchard, Khuchtumur Bum-Erdene, and Matthew W. Hugo, “Inhibitors of Galectins and Implications for Structure-Based Design of Galectin-Specific Therapeutics,” Australian Journal of Chemistry, vol. 67, no. 12, pp. 1763, 2014. View at Publisher · View at Google Scholar
  • Wei Sun, Lian Li, Qingqing Yang, Wei Shan, Zhirong Zhang, and Yuan Huang, “G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment,” Molecular Pharmaceutics, pp. 150929182027007, 2015. View at Publisher · View at Google Scholar
  • Alexander V. Timoshenko, “Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions,” Cellular and Molecular Life Sciences, 2015. View at Publisher · View at Google Scholar
  • Pengfei Lei, Hongbo He, Yihe Hu, and Zhan Liao, “Small interfering RNA-induced silencing of galectin-3 inhibits the malignant phenotypes of osteosarcoma in vitro,” Molecular Medicine Reports, 2015. View at Publisher · View at Google Scholar
  • Isaac Eliaz, Elaine Weil, Julie-Ann Dutton, Audrey E. McCalley, Barbie Nolte, and Patrick M. Moriarty, “Lipoprotein apheresis reduces circulating galectin-3 in humans,” Journal of Clinical Apheresis, 2015. View at Publisher · View at Google Scholar
  • Tao Liu, and Qianxia Huang, “Biodegradable Brush-Type Copolymer Modified with Targeting Peptide as a Nanoscopic Platform for Targeting Drug Delivery to Treat Castration-Resistant Prostate Cancer,” International Journal of Pharmaceutics, 2016. View at Publisher · View at Google Scholar